Holen Sie sich die Stockscreener-App
9.77
4.87%
-0.50
Vorhandelsmarkt:
9.71
-0.06
-0.61%
Schlusskurs vom Vortag:
$10.27
Offen:
$10.22
24-Stunden-Volumen:
4.23M
Relative Volume:
2.24
Marktkapitalisierung:
$848.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-168.09M
KGV:
-4.5023
EPS:
-2.17
Netto-Cashflow:
$-138.01M
1W Leistung:
-11.50%
1M Leistung:
+2.09%
6M Leistung:
+51.00%
1J Leistung:
-42.12%
1-Tages-Spanne:
$8.94
$10.36
1-Wochen-Bereich:
$8.94
$11.05
52-Wochen-Spanne:
$5.41
$19.73
Kura Oncology Inc Stock (KURA) Company Profile
Firmenname
Kura Oncology Inc
Sektor
Branche
Telefon
(858) 500-8800
Adresse
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
Vergleichen Sie KURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KURA
Kura Oncology Inc
|
9.77 | 891.41M | 0 | -168.09M | -138.01M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Eingeleitet | Guggenheim | Neutral |
| 2025-02-06 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-14 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-22 | Eingeleitet | Mizuho | Buy |
| 2023-08-11 | Eingeleitet | BofA Securities | Buy |
| 2023-07-27 | Eingeleitet | Scotiabank | Sector Perform |
| 2023-05-17 | Eingeleitet | BTIG Research | Buy |
| 2023-01-31 | Eingeleitet | Stifel | Buy |
| 2022-07-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-02-15 | Eingeleitet | Jefferies | Buy |
| 2021-05-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-07 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-03 | Eingeleitet | Stifel | Buy |
| 2020-11-05 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Credit Suisse | Outperform |
| 2020-05-05 | Eingeleitet | Barclays | Overweight |
| 2019-07-18 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-09 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-08-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-10-13 | Fortgesetzt | Leerink Partners | Outperform |
| 2016-01-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-30 | Eingeleitet | Oppenheimer | Outperform |
| 2015-12-16 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Kura Oncology Inc Aktie (KURA) Neueste Nachrichten
AlphaQuest LLC Sells 29,555 Shares of Kura Oncology, Inc. $KURA - MarketBeat
Kura Oncology (KURA) Secures $30 Million Milestone Payment - GuruFocus
Kura Oncology receives second $30 million milestone payment from Kyowa Kirin - Investing.com
Kura Oncology (Nasdaq: KURA) receives $30M as second KOMET-017 Phase 3 doses first patient - Stock Titan
Candlestick signals on Kura Oncology Inc. stock todayPortfolio Update Report & Breakout Confirmation Trade Signals - newser.com
Kura Oncology to present ziftomenib combination data at ASH meeting - Investing.com
Kura Oncology (NASDAQ: KURA) to present oral ziftomenib ven/aza data in AML at ASH - Stock Titan
Why Kura Oncology Inc. stock attracts high net worth investorsWeekly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
What To Expect From Kura Oncology Inc (KURA) Q3 2025 Earnings - GuruFocus
Signal strength of Kura Oncology Inc. stock in tech scannersJuly 2025 Volume & Risk Managed Investment Signals - newser.com
Is Kura Oncology (NASDAQ:KURA) Weighed On By Its Debt Load? - simplywall.st
How Kura Oncology Inc. stock reacts to Fed rate cutsPortfolio Profit Report & Expert Verified Movement Alerts - newser.com
How to monitor Kura Oncology Inc. with trend dashboards2025 Market Outlook & Daily Profit Maximizing Trade Tips - newser.com
What momentum indicators show for Kura Oncology Inc. stockMarket Growth Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Can technical indicators confirm Kura Oncology Inc.’s reversalMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com
Applying sector rotation models to Kura Oncology Inc.July 2025 Movers & Safe Capital Growth Tips - newser.com
Understanding Kura Oncology Inc.’s price movement2025 Market WrapUp & Daily Profit Maximizing Trade Tips - newser.com
Kura Oncology's Ziftomenib Poised For Differentiation (NASDAQ:KURA) - Seeking Alpha
What drives Kura Oncology Inc stock priceGap Up/Gap Down Analysis & Tap Into the Fastest-Growing Companies - earlytimes.in
Is Kura Oncology Inc. showing signs of accumulationJuly 2025 Decliners & High Conviction Buy Zone Picks - newser.com
What analysts say about Kura Oncology Inc stockGap Up/Gap Down Analysis & Follow Top Performers in the Community - earlytimes.in
Can Kura Oncology Inc. stock resist market sell offs2025 Retail Activity & Weekly High Return Stock Opportunities - newser.com
Kura Oncology (KURA) to Release Earnings on Thursday - MarketBeat
Kura Oncology Inc. stock momentum explained2025 Price Targets & Low Risk Entry Point Tips - newser.com
Can Kura Oncology Inc. stock rebound after recent weaknessJuly 2025 Short Interest & Capital Efficiency Focused Strategies - newser.com
Kura Oncology’s KO-2806 Study: A New Hope for Advanced Solid Tumors? - The Globe and Mail
Kura Oncology (NASDAQ:KURA) Shares Up 9.1%Still a Buy? - MarketBeat
Kura Oncology to Report Third Quarter 2025 Financial Results - The Manila Times
Finanzdaten der Kura Oncology Inc-Aktie (KURA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):